Expert Analysis

5 Drug Pricing Policy Developments To Watch In 2026

2026 may prove to be a critical year for drug pricing in the U.S., with potential major shifts including several l... (more story)

Regulatory Uncertainty Ahead For Organ Transplant System

Pending court cases against a Centers for Medicare and Medicaid Services final rule that introduced a competition-... (more story)

Key False Claims Act Trends From The Last Year

The False Claims Act remains a powerful enforcement tool after some record verdicts and settlements in 2025, and w... (more story)

Deals & Corporate Governance More

Healthcare Group Of The Year: Holland & Knight

Holland & Knight LLP attorneys advised AdventHealth on its multimillion-dollar outpatient acquisitions, Evernorth Health Services' $3.5 billion investment in Shields Health Solutions and Palomar Health on its ... (more story)

DC Circ. Revives Terrorism Liability Suit Against Pharma Cos.

A D.C. Circuit panel revived a lawsuit Friday accusing pharmaceutical companies of aiding a Hezbollah-linked militia's terrorism in Iraq, saying the victims behind the case have adequately alleged that the com... (more story)

Heart Valve Deal Was Blocked Over Innovation Concerns

The D.C. federal court ruling earlier this month that upended a deal for Edwards Lifesciences Corp. to purchase JenaValve Technology Inc. was based on concerns that the deal would reduce innovation by eliminat... (more story)

Health Tech SPAC Execs Ink $10M Investor Settlement

Former executives of a health technology company that went public via merger with a blank check company have reached a $10 million deal to settle claims they wiped out investors with a bankruptcy filing after ... (more story)

Justices To Clarify What's Fair Game With 'Skinny Labels'

A new U.S. Supreme Court patent case that will require the justices to spell out what generic-drug makers can say when marketing drugs with so-called skinny labels will shape whether and how those companies us... (more story)

Law360 Names Firms Of The Year

Eight law firms have earned spots as Law360's Firms of the Year, with 48 Practice Group of the Year awards among them, achieving milestones such as high-profile litigation wins at the U.S. Supreme Court and 11... (more story)

Digital Health & Technology More

Masimo Chafes Against Apple's Bid To Duck $634M IP Verdict

Masimo has urged a California federal court to turn down Apple's request for relief from its $634 million trial loss in the companies' patent infringement fight over the Apple Watch, arguing that the company h... (more story)

AI Diagnostics Co.'s Patent Claims Don't Pass Alice Test

A California federal judge has thrown out artificial intelligence diagnostics company Tempus AI's patent infringement suit against medical test-maker Guardant Health, finding claims in the patents weren't pate... (more story)

GoodRx Users Denied Nod For $32M Deal In Data Sharing Row

A California federal judge refused to sign off on a $32 million deal to resolve a proposed class action accusing GoodRx of illegally sharing users' sensitive health data with fellow defendant Criteo and other ... (more story)

Law360 Names Practice Groups Of The Year

Law360 would like to congratulate the winners of its Practice Groups of the Year awards for 2025, which honor the attorney teams behind litigation wins and significant transaction work that resonated throughou... (more story)

Insights From 2025's Flood Of Data Breach Litigation

Several coherent patterns emerged from 2025's data breach litigation activity, suggesting that judges have grown skilled at distinguishing between companies that were genuinely victimized by sophisticated crim... (more story)

Call Vendors Skirt Wiretap Suit Over AI Transcription Tool

An Illinois federal judge has released dental support organization Heartland Dental LLC and its contractor from a proposed class action accusing them of illegally using an artificial intelligence-powered note-... (more story)

Policy & Compliance More

Generics Makers Fight Cert. In Cholesterol Drug Pricing MDL

Generic-drug makers sought to defeat a bid to certify proposed classes comprising thousands of pharmacies that indirectly purchased and resold generics at the center of sprawling price-fixing litigation, telli... (more story)

Record FCA Haul Sends 'Loud' Message On Federal Priorities

Aggressive enforcement by President Donald Trump's administration and the qui tam bar's success prosecuting fraud even without government intervention helped fuel the explosion in recoveries under the False Cl... (more story)

Anthem Seeks Dismissal Of 'Ghost Network' Class Action

A proposed class action's allegations that Anthem Health Plans maintains inaccurate mental health directories known as ghost provider networks aren't true and are "legally deficient," the insurer and its paren... (more story)

3rd Circ. Finds NJ Officials Shielded From COVID Deaths Suit

A proposed class action on behalf of the families of roughly 10,000 nursing home residents who died early in the COVID-19 pandemic cannot proceed against New Jersey officials over their response, the Third Cir... (more story)

Novo Nordisk Faces Class Claims Over GLP-1 Patent Tactics

A South Carolina drug company has launched a proposed class action against major pharmaceutical company Novo Nordisk, alleging it engaged in anticompetitive behavior to prolong its monopoly against generic com... (more story)

Providers Oppose Credit Bureaus' Medical Debt Appeal

A proposed class of medical providers and collection agencies accusing Equifax, Experian and TransUnion of colluding to exclude medical debt under $500 from consumer credit reports is opposing a bid by the cre... (more story)